Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial
PaperCitations, authors & open-access status
Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 101 citations, 2019 year and bronze oa status.
101
Citations
2019
Year
bronze
OA Status